These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 33999375
1. Isolated angioedema of the bowel caused by aspirin. Osman K, Kendi AT, Maselli D. Clin J Gastroenterol; 2021 Aug; 14(4):1096-1102. PubMed ID: 33999375 [Abstract] [Full Text] [Related]
2. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis. Chaudhry T, Hissaria P, Wiese M, Heddle R, Kette F, Smith WB. Intern Med J; 2012 Jun; 42(6):665-71. PubMed ID: 21981353 [Abstract] [Full Text] [Related]
3. Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide. Inomata N, Osuna H, Yamaguchi J, Onoda M, Takeshita Y, Chiba Y, Kambara T, Ikezawa Z. J Dermatol; 2007 Mar; 34(3):172-7. PubMed ID: 17291297 [Abstract] [Full Text] [Related]
4. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema. Göksel O, Aydin O, Misirligil Z, Demirel YS, Bavbek S. J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786 [Abstract] [Full Text] [Related]
5. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. Kowalski ML, Woessner K, Sanak M. J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051 [Abstract] [Full Text] [Related]
6. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Doña I, Blanca-López N, Jagemann LR, Torres MJ, Rondón C, Campo P, Gómez AI, Fernández J, Laguna JJ, Rosado A, Blanca M, Canto G. Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936 [Abstract] [Full Text] [Related]
7. Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions. Saff RR, Banerji A. Allergy Asthma Proc; 2015 Nov; 36(1):34-9. PubMed ID: 25562554 [Abstract] [Full Text] [Related]
8. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Blanca-Lopez N, J Torres M, Doña I, Campo P, Rondón C, Seoane Reula ME, Salas M, Canto G, Blanca M. Clin Exp Allergy; 2013 Jan; 43(1):85-91. PubMed ID: 23278883 [Abstract] [Full Text] [Related]
9. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema. Doña I, Barrionuevo E, Salas M, Cornejo-García JA, Perkins JR, Bogas G, Prieto A, Torres MJ. Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401 [Abstract] [Full Text] [Related]
10. Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: an expert panel review. Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Cortellini G, Nizankowska-Mogilnicka E, Quaratino D, Romano A, Sanchez-Borges M, Torres-Jaen MJ. Int Arch Allergy Immunol; 2013 Sep; 160(2):126-33. PubMed ID: 23018315 [Abstract] [Full Text] [Related]
12. Allergic reactions to nonsteroidal anti-inflammatory drugs: is newer better? Berges-Gimeno MP, Martín-Lázaro J. Curr Allergy Asthma Rep; 2007 Apr; 7(1):35-40. PubMed ID: 17504659 [Abstract] [Full Text] [Related]
13. [Analysis of 76 patients with urticaria and angioedema induced by non-steroidal anti-inflammatory drugs (NSAIDs) in Japan]. Moriya M, Aihara M, Hirota R, Hirata Y, Ikinaga N, Takamura N, Kunimi Y, Uchida T, Ikezawa Z. Arerugi; 2011 Jun; 60(6):699-707. PubMed ID: 21709437 [Abstract] [Full Text] [Related]
15. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Asero R. Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483 [Abstract] [Full Text] [Related]
16. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Kidon MI, Kang LW, Chin CW, Hoon LS, See Y, Goh A, Lin JT, Chay OM. Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465 [Abstract] [Full Text] [Related]
18. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765 [Abstract] [Full Text] [Related]
19. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema. Nosbaum A, Braire-Bourrel M, Dubost R, Faudel A, Parat S, Nicolas JF, Bérard F. Ann Allergy Asthma Immunol; 2013 Apr; 110(4):263-6. PubMed ID: 23535090 [Abstract] [Full Text] [Related]